Io Biotech Stock Market Value
| IOBT Stock | USD 0.75 0.04 5.63% |
| Symbol | IOBT |
IO Biotech Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IO Biotech. If investors know IOBT will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IO Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.29) | Return On Assets (0.51) | Return On Equity (0.88) |
The market value of IO Biotech is measured differently than its book value, which is the value of IOBT that is recorded on the company's balance sheet. Investors also form their own opinion of IO Biotech's value that differs from its market value or its book value, called intrinsic value, which is IO Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IO Biotech's market value can be influenced by many factors that don't directly affect IO Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IO Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if IO Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IO Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
IO Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to IO Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of IO Biotech.
| 08/28/2024 |
| 11/26/2024 |
If you would invest 0.00 in IO Biotech on August 28, 2024 and sell it all today you would earn a total of 0.00 from holding IO Biotech or generate 0.0% return on investment in IO Biotech over 90 days. IO Biotech is related to or competes with Pmv Pharmaceuticals, Eliem Therapeutics, MediciNova, Pharvaris, PepGen, Shattuck Labs, and Champions Oncology. IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T... More
IO Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure IO Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess IO Biotech upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 69.64 | |||
| Value At Risk | (10.57) | |||
| Potential Upside | 7.48 |
IO Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for IO Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as IO Biotech's standard deviation. In reality, there are many statistical measures that can use IO Biotech historical prices to predict the future IO Biotech's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (1.11) | |||
| Total Risk Alpha | (2.24) | |||
| Treynor Ratio | (0.28) |
IO Biotech Backtested Returns
IO Biotech retains Efficiency (Sharpe Ratio) of -0.0776, which attests that the entity had a -0.0776% return per unit of price deviation over the last 3 months. IO Biotech exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out IO Biotech's Market Risk Adjusted Performance of (0.27), information ratio of (0.1), and Coefficient Of Variation of (1,217) to validate the risk estimate we provide. The company owns a Beta (Systematic Risk) of 2.76, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, IO Biotech will likely underperform. At this point, IO Biotech has a negative expected return of -0.74%. Please make sure to check out IO Biotech's jensen alpha, as well as the relationship between the skewness and day median price , to decide if IO Biotech performance from the past will be repeated sooner or later.
Auto-correlation | -0.17 |
Insignificant reverse predictability
IO Biotech has insignificant reverse predictability. Overlapping area represents the amount of predictability between IO Biotech time series from 28th of August 2024 to 12th of October 2024 and 12th of October 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of IO Biotech price movement. The serial correlation of -0.17 indicates that over 17.0% of current IO Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.17 | |
| Spearman Rank Test | -0.38 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
IO Biotech lagged returns against current returns
Autocorrelation, which is IO Biotech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting IO Biotech's stock expected returns. We can calculate the autocorrelation of IO Biotech returns to help us make a trade decision. For example, suppose you find that IO Biotech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
IO Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If IO Biotech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if IO Biotech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in IO Biotech stock over time.
Current vs Lagged Prices |
| Timeline |
IO Biotech Lagged Returns
When evaluating IO Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of IO Biotech stock have on its future price. IO Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, IO Biotech autocorrelation shows the relationship between IO Biotech stock current value and its past values and can show if there is a momentum factor associated with investing in IO Biotech.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for IOBT Stock Analysis
When running IO Biotech's price analysis, check to measure IO Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IO Biotech is operating at the current time. Most of IO Biotech's value examination focuses on studying past and present price action to predict the probability of IO Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IO Biotech's price. Additionally, you may evaluate how the addition of IO Biotech to your portfolios can decrease your overall portfolio volatility.